IPXL
Impax Laboratories, Inc.
IPXL
IPXL
Delisted
IPXL was delisted on the 4th of May, 2018.
188 hedge funds and large institutions have $1.42B invested in Impax Laboratories, Inc. in 2018 Q1 according to their latest regulatory filings, with 24 funds opening new positions, 64 increasing their positions, 63 reducing their positions, and 35 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
188
Holders Change
-12
Holders Change %
-6%
% of All Funds
4.31%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
24
Increased
64
Reduced
63
Closed
35
Calls
$2.13M
Puts
$276K
Net Calls
+$1.85M
Net Calls Change
+$759K
Top Buyers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$89M |
| 2 |
FCM
Frontier Capital Management
Boston,
Massachusetts
|
+$11.5M |
| 3 |
Morgan Stanley
New York
|
+$10.9M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$7.92M |
| 5 |
TG
TCW Group
Los Angeles,
California
|
+$6.9M |
Top Sellers
| 1 |
MC
Maverick Capital
Dallas,
Texas
|
-$63.9M |
| 2 |
Janus Henderson Group
London,
United Kingdom
|
-$19.7M |
| 3 |
Alyeska Investment Group
Chicago,
Illinois
|
-$18.7M |
| 4 |
Renaissance Technologies
New York
|
-$18.2M |
| 5 |
HSBC Holdings
London,
United Kingdom
|
-$7.81M |
